(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPOCRIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OPOCRIN

ST13

US500000079226268

Class

1, 5

Filing

79226268

Registration

5548005

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

10/10/2024

Trademark type

Combined

Nice classes

1, 5

Filing date

12/18/2017

Registration date

08/28/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/10/2024

Last transaction

10/10/2024

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

3

Owner type

35

Owner location

Corlo di Formigine (MO), IT

Examiner

TRUSILO, KELLY

Current location

Historical data usage

Mark description

The mark consists of the word "OPOCRIN" appearing in blue to the right of an incomplete circular design with a curved cut-out feature in orange with yellow highlights. The color white appears as shading and is not part of the mark.

Holders and representatives

Holders

OPOCRIN S.p.A.
OPOCRIN S.p.A.

Representatives

ROBERT S. BRODER COLLARD & ROE, P.C.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals

Class 5

Chemical preparations for pharmaceutical or medical purposesfor treating Respiratory Distress Syndrome (RDS) in premature infantsfor preventing venous and arterial thrombosis and cardiovascular disease and for the treatment of iron deficiency anemia; enzymes for medical purposes

Publications

History of USPTO decisions and trademark events.

32 publications found

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

10/10/2024

71AG

REGISTERED-SEC.71 ACCEPTED

10/10/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/07/2024

ES71

TEAS SECTION 71 RECEIVED

02/20/2024

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/27/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/14/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/01/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/27/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/17/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/28/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

12/08/2018

FIMP

FINAL DISPOSITION PROCESSED

12/08/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/28/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

08/28/2018

PUBO

PUBLISHED FOR OPPOSITION

06/12/2018

GPNX

NOTIFICATION PROCESSED BY IB

06/08/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/23/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/23/2018

NPUB

NOTICE OF PUBLICATION

05/23/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/09/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/08/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/08/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/08/2018

RFNT

REFUSAL PROCESSED BY IB

04/20/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/02/2018

RFRR

REFUSAL PROCESSED BY MPU

04/02/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/29/2018

CNRT

NON-FINAL ACTION WRITTEN

03/28/2018

DOCK

ASSIGNED TO EXAMINER

03/27/2018

MAFR

APPLICATION FILING RECEIPT MAILED

02/13/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/09/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/08/2018

Continuous trademark protection

Get notified about every new filing that threatens OPOCRIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.